Related by context. Frequent words. (Click for all words.) 71 Commercialization Agreement 67 Collaboration Agreement 66 Patent License Agreement 63 Licence Agreement 63 Licensing Agreements 62 License Agreement 61 Exclusive License 61 Inc Therapeutic Competitors 61 Archemix Corp. 61 Paladin Labs 61 Progenics Pharmaceuticals 61 BioDelivery Sciences 60 NASDAQ CRXL 60 Presents Positive 60 FDA Accepts 60 Javelin Pharmaceuticals 60 Licensing Agreement 59 Nasdaq VRTX 59 Generex Biotechnology 59 Crucell NV Euronext 59 Trubion Pharmaceuticals 59 Nippon Kayaku 58 GlaxoSmithKline plc GSK 58 Inc. Nasdaq IMGN 58 Combination Agreement 58 Director Shareholding 58 NASDAQ SHPGY 58 submitted Biologics License 58 Termination Agreement 58 FDA Clears 58 Exploit collaboration 58 Definitive Agreements 58 Option Grants 58 Patent Covering 58 pSivida Limited 58 Supply Agreements 58 DepoMed 58 Idera Pharmaceuticals 58 Anika Therapeutics 57 Clinical Trial Results 57 TSX AMB 57 Merck KGaA Darmstadt Germany 57 Assignment Agreement 57 Exclusivity Agreement 57 Distribution Agreements 57 submitted Marketing Authorization 57 Ono Pharmaceutical 57 Confidentiality Agreement 57 Amended Agreement 57 Announces Initiation 57 RNAi Therapeutics 57 pediatric exclusivity 57 NASDAQ DYAX 57 Generic Version 57 Barrier Therapeutics Inc. 57 Drug Candidate 57 AnGes 57 Teaming Agreement 57 Vicuron Pharmaceuticals 57 Merck Serono division 57 Distributor Agreement 57 Patent Infringement Case 56 Sunesis Pharmaceuticals 56 Nasdaq BIIB 56 SCHWARZ PHARMA 56 Completes Enrollment 56 Evotec AG 56 Securities Purchase Agreement 56 Pennsaid R 56 Committed Equity 56 Ligand Pharmaceuticals Incorporated 56 Completes Tender Offer 56 anti CD# monoclonal 56 Cetrorelix 56 Patent Lawsuit 56 Patent Issued 56 Janssen Pharmaceutica NV 56 Biotest AG 56 OMJPI 55 Novexel 55 AEterna 55 Monoclonal Antibody 55 Repligen Corporation 55 Esprit Pharma 55 Purchase Agreement dated 55 Inc. Nasdaq NVAX 55 Subsequent Offering 55 XTL Biopharmaceuticals Ltd. 55 binding Letter 55 outlicensing 55 Metabasis Therapeutics Inc. 55 Enzo Biochem 55 Andrx Corporation 55 Announces Definitive Agreement 55 Tekmira Pharmaceuticals Corporation 55 Kyorin 55 Durect 55 Nymox Pharmaceutical Corporation 55 NYSE PFE 55 Hybridon 55 Patent Infringement Lawsuit